"First results from a human trial of an Ebola vaccine from GlaxoSmithKline show it is safe and generates an immune response, scientists said on Wednesday, but larger trials are needed to see if it protects and if a booster is needed."

"The early-stage Phase I trial of GSK's vaccine was primarily designed to test safety, but Adrian Hill, who led the work at Oxford's Jenner Institute, said it was 'encouraging' that the shot also prompted responses from the immune system."

"However, the antibody response was weaker than was found in a trial of the same Ebola vaccine in macaque monkeys, in which the animals were also found to be protected."

"Hill said the lower antibody levels, together with a lower response detected in the immune system's T-cells, suggested to him that a booster may well be needed."

From +Reuters: http://ow.ly/IlABf

Embedded Link

Trial finds GSK Ebola shot is safe and provokes immune response


Comments are closed.